Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia
Study data from M. Gross and co-authors update knowledge of acute myeloid leukemia
March 24th, 2009
"Acute myeloid leukemia (AML) is a heterogeneous disease with respect to clinical Prognosis and acquired chromosomal aberrations. After routine banding cytogenetic analysis 45% of AML patients snow a normal karyotype (NK-AML)," scientists in Jena, Germany report. "For a better understanding of development and progression in AML, it is important to find markers which could be primary genetic aberrations. Therefore, in this study 31 patients with NK-AML were analyzed by new high resolution molecular cytogenetic approaches. A combination Of Multitude multicolor banding and metaphase microdissection-based comparative genomic hybridization revealed deletions of the...
Source: Cancer Weekly (2009-03-24)
|
